An improved assay shows no association between the CYP2A6 gene and cigarette smoking behavior

Behavior Genetics

Volumn 29, Issue 4, 1999, Pages 257-261

  Sabol, Sue Z ^a   Hamer, Dean H ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CYP2A6 gene; Cytochrome P450; Genetics; Nicotine; Smoking

Indexed keywords

CYTOCHROME P450; ISOENZYME;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CIGARETTE SMOKING; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 0032758624     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021642323602     Document Type: Article

References (20)

1. Benjamin, J., Li, L., Patterson, C., Greenberg, B. D., Murphy, D. L., and Hamer, D. H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet. 12:81-84.
2. Carmelli, D., Swan, G. E., Robinette, D., and Fabsitz, R. (1992). Genetic influence on smoking: a study of male twins. N. Engl. J. Med. 327:829-833.
3. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Erlbaum, Hillsdale, NJ.
4. Fernandez-Salguero, P., Hoffman, S. M., Cholerton, S., Mohrenweiser, H., Raunio, H., Rautio, A., Pelkonen, O., Huang, J. D., Evans, W. E., Idle, J. R., et al. (1995). A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 57:651-660.
5. Gullsten, H., Agundez, J. A., Benitez, J., Laara, E., Ladero, J. M., Diaz-Rubio, M., Fernandez-Salguero, P., Gonzalez, F., Rautio, A., Pelkonen, O., and Raunio, H. (1997). CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis. Pharmacogenetics 7:247-250.
6. Hadidi, H., Zahlsen, K., Idle, J. R., and Cholerton, S. (1997). A single amino acid substitution (Leul60His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem. Toxicol. 35:903-907.
7. Hamer, D. H., and Copeland, P. (1994). The Science of Desire, Simon and Schuster, New York.
8. Heath, A. C., and Madden, P. G. (1995). Genetic influences on smoking behavior. In Turner, J. R., Cardon, L. R., and Hewitt, J. K. (eds.), Behavior Genetic Approaches in Behavioral Medicine, Plenum, New York, pp. 37-48.
9. Heath, A. C., and Martin, N. (1993). Genetic models for the natural history of smoking: Evidence for a genetic influence on smoking persistence. Addict. Behav. 18:19-34.
10. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., and Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fgerstrom Tolerance Questionnaire. Br. J. Addict. 86:1119-1127.
11. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., and Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
12. London, S. J., Idle, J. R., Daly, A. K., and Coetzee, G. A. (1999). Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353:898-899.
13. Miles, J. S., McLaren, A. W., Forrester, L. M., Glancey, M. J., Lang, M. A., and Wolf, C. R. (1990). Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem. J. 267:365-371.
14. Nunoya, K., Yokoi, T., Kimura, K., Inoue, K., Kodama, T., Funayama, M., Nagashima, K., Funae, Y., Green, C., Kinoshita, M., and Kamataki, T. (1998). A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin. Pharmacogenetics 8:239-249.
15. Oscarson, M., Gullsten, H., Rautio, A., Bernal, M. L., Sinues, B., Dahl, M. L., Stengard, J. H., Pelkonen, O., Raunio, H., and Ingelman-Sundberg, M. (1998). Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett. 438:201-205.
16. Pianezza, M. L., Sellers, E. M., and Tyndale, R. F. (1998). Nicotine metabolism defect reduces smoking. Nature 25:750-751.
17. Pomerleau, C. S., Carton, S. M., Lutzke, M. L., Flessland, K. A., and Pomerleau, O. F. (1994). Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict. Behav. 19:33-39.
18. Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Lucas, F. R., IV, Benjamin, J., Murphy, D. L., and Hamer, D. H. (1999). A genetic association for cigarette smoking behavior. Health Psychol. 18:7-13.
19. Yamano, S., Tatsuno, J., and Gonzalez, F. J. (1990). The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in liver microsomes. Biochemistry 29:1322-1329.
20. Yokoi, T., and Kamataki, T. (1998). Genetic polymorphism of drug metabolizing enzymes: New mutations in CYPD6 and CYP2A6 genes in Japanese. Pharm. Res. 15:517-524.